Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia

Journal of Dermatological Science

Volumn 58, Issue 1, 2010, Pages 43-54

  Imanishi, Hisayoshi ^a   Tsuruta, Daisuke ^a   Tateishi, Chiharu ^a   Sugawara, Koji ^a,b   Paus, Ralf ^b   Tsuji, Tsutomu ^c   Ishii, Masamitsu ^a   Ikeda, Kazuo ^d   Kunimoto, Hiroyuki ^a   Nakajima, Koichi ^a   Jones, Jonathan C R ^e   Kobayashi, Hiromi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c HOSHI UNIVERSITY   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

A549 cells; Chemotherapy; Extracellular matrix; Hemidesmosome; Integrin; Outer root sheath cells

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ALPHA3 INTEGRIN; ALPHA6BETA4 INTEGRIN; BETA4 INTEGRIN; CYCLOPHOSPHAMIDE; KALININ; LAMININ 10; LAMININ ALPHA3A; LAMININ ALPHA5; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ALOPECIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOTHERAPY INDUCED ALOPECIA; CONTROLLED STUDY; DOWN REGULATION; DRUG SCREENING; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HAIR FOLLICLE; HAIR GROWTH; HAIR ROOT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA TRANSLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ALOPECIA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION MOLECULES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; HAIR; HAIR FOLLICLE; INJECTIONS, INTRADERMAL; INTEGRIN ALPHA3; INTEGRIN BETA4; LAMININ; MICE; MICE, INBRED C57BL; UP-REGULATION;

EID: 77950370242     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.02.005     Document Type: Article

References (38)

1. Sausville E.A., Longo D.L. Principles of cancer treatment. Harrison's principles of internal medicine 2008, vol. 1:514-533. McGraw-Hill, New York. 17th ed.
2. Hashimoto T., Ito M. Drug-induced alopecia. Comprehensive handbook of clinical dermatology 2002, vol. 17:45-52. Nakayamashoten, Tokyo.
3. Cece R., Cazzaniga S., Morelli D., Sfondrini L., Bignotto M., Menard S., et al. Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats. Lab Invest 1996, 75:601-609.
4. Müller-Röver S., Rossiter H., Lindner G., Peters E.M., Kupper T.S., Paus R. Hair follicle apoptosis and bcl-2. J Investig Dermatol Symp Proc 1999, 4:272-277.
5. Schilli M.B., Paus R., Menrad A. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs. J Invest Dermatol 1998, 111:598-604.
6. Takahata K., Tada M., Yazawa K., Tamaki T. Protection from chemotherapy-induced alopecia by docosahexaenoic acid. Lipids 1999, 34(Suppl.):S105.
7. Paus R., Handjiski B., Eichmüller S., Czarnetzki B.M. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine a, and modulation by dexamethasone. Am J Pathol 1994, 144:719-734.
8. Sullivan R.D., Mescon H., Jones R. The effect of intra-arterial nitrogen-mustard therapy on human skin. Cancer 1953, 6:288-293.
9. Hendrix S., Handjiski B., Peters E.M., Paus R. A guide to assessing damage response pathways of the hair follicle: Lessons from cyclophosphamide-induced alopecia in mice. J Invest Dermatol 2005, 125:42-51.
10. Perez J.E., Macchiavelli M., Leone B.A., Romero A., Rabinovich M.G., Goldar D., et al. High-dose alpha-tocopherol as a preventive of doxorubicin-induced alopecia. Cancer Treat Rep 1986, 70:1213-1214.
11. Wood L.A. Possible prevention of adriamycin-induced alopecia by tocopherol. N Engl J Med 1985, 312:1060.
12. Martin-Jimenez M., Diaz-Rubio E., Gonzalez Larriba J.L., Sangro B. Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin. N Engl J Med 1986, 315:894-895.
13. Duvic M., Lemak N.A., Valero V., Hymes S.R., Farmer K.L., Hortobagyi G.N., et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 1996, 35:74-78.
14. Granai C.O., Frederickson H., Gajewski W., Goodman A., Goldstein A., Baden H. The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaecol Oncol 1991, 12:129-132.
15. Rodriguez R., Machiavelli M., Leone B., Romero A., Cuevas M.A., Langhi M., et al. Minoxidil (mx) as a prophylaxis of doxorubicin--induced alopecia. Ann Oncol 1994, 5:769-770.
16. Gregory R.P., Cooke T., Middleton J., Buchanan R.B., Williams C.J. Prevention of doxorubicin-induced alopedia by scalp hypothermia: Relation to degree of cooling. Br Med J (Clin Res Ed) 1982, 284:1674.
17. Tollenaar R.A., Liefers G.J., Repelaer van Driel O.J., van de Velde C.J. Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer. Eur J Cancer 1994, 30A:1448-1453.
18. Sugawara K., Tsuruta D., Kobayashi H., Ikeda K., Hopkinson S.B., Jones J.C., Ishii M. Spatial and temporal control of laminin-332 (5) and -511 (10) expression during induction of anagen hair growth. J Histochem Cytochem 2007, 55:43-55.
19. Li J., Tzu J., Chen Y., Zhang Y.P., Nguyen N.T., Gao J., et al. Laminin-10 is crucial for hair morphogenesis. EMBO J 2003, 22:2400-2410.
20. Gao J., DeRouen M.C., Chen C.H., Nguyen M., Nguyen N.T., Ido H., et al. Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. Genes Dev 2008, 22:2111-2124.
21. Langhofer M., Hopkinson S.B., Jones J.C. The matrix secreted by 804g cells contains laminin-related components that participate in hemidesmosome assembly in vitro. J Cell Sci 1993, 105(Pt 3):753-764.
22. DiPersio C.M., Shah S., Hynes R.O. Alpha 3a beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J Cell Sci 1995, 108(Pt 6):2321-2336.
23. Miner J.H., Patton B.L., Lentz S.I., Gilbert D.J., Snider W.D., Jenkins N.A., et al. The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform. J Cell Biol 1997, 137:685-701.
24. Tiger C.F., Champliaud M.F., Pedrosa-Domellof F., Thornell L.E., Ekblom P., Gullberg D. Presence of laminin alpha5 chain and lack of laminin alpha1 chain during human muscle development and in muscular dystrophies. J Biol Chem 1997, 272:28590-28595.
25. Fessing M.Y., Sharova T.Y., Sharov A.A., Atoyan R., Botchkarev V.A. Involvement of the edar signaling in the control of hair follicle involution (catagen). Am J Pathol 2006, 169:2075-2084.
26. Bodó E., Tobin D.J., Kamenisch Y., Biró T., Berneburg M., Funk W., et al. Dissecting the impact of chemotherapy on the human hair follicle: A pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol 2007, 171:1153-1167.
27. Philpott M.P., Green M.R., Kealey T Human hair growth in vitro. J Cell Sci 1990, 97(Pt 3):463-471.
28. Peters E.M., Liotiri S., Bodó E., Hagen E., Biró T., Arck P.C., et al. Probing the effects of stress mediators on the human hair follicle: substance p holds central position. Am J Pathol 2007, 171:1872-1886.
29. Telek A., Biró T., Bodó E., Toth B.I., Borbiro I., Kunos G., et al. Inhibition of human hair follicle growth by endo- and exocannabinoids. FASEB J 2007, 21:3534-3541.
30. Rooney J.E., Gurpur P.B., Burkin D.J. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2009, 106:7991-7996.
31. Kato T., Katabami K., Takatsuki H., Han S.A., Takeuchi K., Irimura T., et al. Characterization of the promoter for the mouse alpha 3 integrin gene. Eur J Biochem 2002, 269:4524-4532.
32. Tateishi C, Tsuruta D, Sugawara K, Imanishi H, Nishida K, Ishii M, et al. Spatial and temporal control of laminin-511 and -332 expressions during catagen. J Cell Sci (in press).
33. Botchkarev V.A., Komarova E.A., Siebenhaar F., Botchkareva N.V., Komarov P.G., Maurer M., et al. P53 is essential for chemotherapy-induced hair loss. Cancer Res 2000, 60:5002-5006.
34. Davis S.T., Benson B.G., Bramson H.N., Chapman D.E., Dickerson S.H., Dold K.M., et al. Prevention of chemotherapy-induced alopecia in rats by cdk inhibitors. Science 2001, 291:134-137.
35. Sharov A.A., Siebenhaar F., Sharova T.Y., Botchkareva N.V., Gilchrest B.A., Botchkarev V.A. Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Res 2004, 64:6266-6270.
36. Müller-Röver S., Rossiter H., Paus R., Handjiski B., Peters E.M., Murphy J.E., et al. Overexpression of bcl-2 protects from ultraviolet b-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia. Am J Pathol 2000, 156:1395-1405.
37. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626.
38. Conti F.J., Rudling R.J., Robson A., Hodivala-Dilke K.M. Alpha3beta1-integrin regulates hair follicle but not interfollicular morphogenesis in adult epidermis. J Cell Sci 2003, 116:2737-2747.